VivoSim Labs
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VivoSim Labs and other ETFs, options, and stocks.About VIVS
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
CEOKeith Murphy
CEOKeith Murphy
Employees13
Employees13
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees13
Employees13
VIVS Key Statistics
Market cap6.00M
Market cap6.00M
Price-Earnings ratio-2.89
Price-Earnings ratio-2.89
Dividend yield—
Dividend yield—
Average volume43.60K
Average volume43.60K
High today$2.40
High today$2.40
Low today$2.14
Low today$2.14
Open price$2.35
Open price$2.35
Volume13.92K
Volume13.92K
52 Week high$21.96
52 Week high$21.96
52 Week low$1.41
52 Week low$1.41
Stock Snapshot
As of today, VivoSim Labs(VIVS) shares are valued at $2.30. The company's market cap stands at 6M, with a P/E ratio of -2.89.
On 2025-12-05, VivoSim Labs(VIVS) stock traded between a low of $2.14 and a high of $2.40. Shares are currently priced at $2.30, which is +7.5% above the low and -4.2% below the high.
The VivoSim Labs(VIVS)'s current trading volume is 13.92K, compared to an average daily volume of 43.6K.
In the last year, VivoSim Labs(VIVS) shares hit a 52-week high of $21.96 and a 52-week low of $1.41.
In the last year, VivoSim Labs(VIVS) shares hit a 52-week high of $21.96 and a 52-week low of $1.41.
People also own
Based on the portfolios of people who own VIVS. This list is generated using Robinhood data, and it’s not a recommendation.